These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16870714)

  • 1. Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I.
    Wang XP; Goodwin L; Kahn P; Gawel C; Cunha CB; Laser B; Sahn B; Kaplan MH
    J Biomol Tech; 2006 Jul; 17(3):228-39. PubMed ID: 16870714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ lymphocyte values and trends in individuals infected with human immunodeficiency virus and/or co-infected with hepatitis C virus in the Gambia.
    Mboto CI; Davies-Russell A; Fielder M; Jewell AP
    Afr Health Sci; 2009 Sep; 9(3):130-6. PubMed ID: 20589139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
    Taye S; Lakew M
    BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.
    Chung RT; Evans SR; Yang Y; Theodore D; Valdez H; Clark R; Shikuma C; Nevin T; Sherman KE;
    AIDS; 2002 Sep; 16(14):1915-23. PubMed ID: 12351951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus.
    Toyoda H; Fukuda Y; Koyama Y; Takamatsu J; Saito H; Hayakawa T
    J Hepatol; 1997 May; 26(5):975-82. PubMed ID: 9186827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy.
    Sede M; Parra M; Manrique JM; Laufer N; Jones LR; Quarleri J
    Infect Genet Evol; 2016 Sep; 43():186-96. PubMed ID: 27234841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.
    Yokozaki S; Takamatsu J; Nakano I; Katano Y; Toyoda H; Hayashi K; Hayakawa T; Fukuda Y
    Blood; 2000 Dec; 96(13):4293-9. PubMed ID: 11110704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher dN/dS ratios in the HCV core gene, but not in the E1/HVR1 gene, are associated with human immunodeficiency virus-associated immunosuppression.
    Xu CH; Shen T; Zheng JJ; Tu J; Zhang WD; Lu FM
    Arch Virol; 2012 Nov; 157(11):2153-62. PubMed ID: 22825695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
    Torti C; Costarelli S; De Silvestri A; Quiros-Roldan E; Lapadula G; Cologni G; Paraninfo G; Castelnuovo F; Puoti M; Carosi G;
    Drug Saf; 2007; 30(12):1161-9. PubMed ID: 18035868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.
    Yacisin K; Maida I; Ríos MJ; Soriano V; Núñez M
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):935-40. PubMed ID: 18593347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.
    Babik JM; Holodniy M
    J Virol; 2003 Feb; 77(3):1940-50. PubMed ID: 12525628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients.
    Bernini F; Ebranati E; De Maddalena C; Shkjezi R; Milazzo L; Lo Presti A; Ciccozzi M; Galli M; Zehender G
    PLoS One; 2011 Jan; 6(1):e16551. PubMed ID: 21304985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
    Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
    Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
    Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
    Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
    Neau D; Jouvencel AC; Legrand E; Trimoulet P; Galperine T; Chitty I; Ventura M; Le Bail B; Morlat P; Lacut JY; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    J Med Virol; 2003 Sep; 71(1):41-8. PubMed ID: 12858407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.